These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31663480)

  • 1. A Paradigm Shift in the Development of Anti-Candida Drugs.
    Gowda DV; Afrasim M; Meenakshi SI; Manohar M; Hemalatha S; Siddaramaiah H; Sathishbabu P; Rizvi SMD; Hussain T; Kamal MA
    Curr Top Med Chem; 2019; 19(28):2610-2628. PubMed ID: 31663480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of Medicinal Plants as Sources of Novel Anticandidal Drugs.
    Kumar A; Khan F; Saikia D
    Curr Top Med Chem; 2019; 19(28):2579-2592. PubMed ID: 31654513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Complexity and the Need for Advanced Drug Delivery in Targeting Candida Species.
    Wadhwa R; Pandey P; Gupta G; Aggarwal T; Kumar N; Mehta M; Satija S; Gulati M; Madan JR; Dureja H; Balusamy SR; Perumalsamy H; Maurya PK; Collet T; Tambuwala MM; Hansbro PM; Chellappan DK; Dua K
    Curr Top Med Chem; 2019; 19(28):2593-2609. PubMed ID: 31746290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Potential of Phytomedicines and Novel Polymeric Strategies for Significant Management of Candidiasis.
    Rohilla S; Bhatt DC; Gupta A
    Curr Pharm Des; 2018; 24(16):1748-1765. PubMed ID: 29792138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future therapies targeted towards eliminating Candida biofilms and associated infections.
    Bandara HM; Matsubara VH; Samaranayake LP
    Expert Rev Anti Infect Ther; 2017 Mar; 15(3):299-318. PubMed ID: 27927053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida and candidiasis: the cell wall as a potential molecular target for antifungal therapy.
    Gozalbo D; Roig P; Villamón E; Gil ML
    Curr Drug Targets Infect Disord; 2004 Jun; 4(2):117-35. PubMed ID: 15180460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antifungal activity of cassia fistula extracts against fluconazole resistant strains of Candida species from HIV patients.
    Sony P; Kalyani M; Jeyakumari D; Kannan I; Sukumar RG
    J Mycol Med; 2018 Mar; 28(1):193-200. PubMed ID: 28838629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical composition, antioxidant activity and antifungal effects of five Iranian essential oils against Candida strains isolated from urine samples.
    Khosravi AR; Sharifzadeh A; Nikaein D; Almaie Z; Gandomi Nasrabadi H
    J Mycol Med; 2018 Jun; 28(2):355-360. PubMed ID: 29477783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights on the anticandidal activity of non-antifungal drugs.
    Moraes DC; Ferreira-Pereira A
    J Mycol Med; 2019 Sep; 29(3):253-259. PubMed ID: 31399349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of resistance to amphotericin B during therapy for Candida glabrata infection in an immunocompetent host.
    Sterling TR; Gasser RA; Ziegler A
    Clin Infect Dis; 1996 Jul; 23(1):187-8. PubMed ID: 8816156
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological advances in the treatment of invasive candidiasis.
    Deck DH; Guglielmo BJ
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of nanoparticles as alternative therapeutic agents against Candida infections: an up-to-date overview and future perspectives.
    Mba IE; Nweze EI
    World J Microbiol Biotechnol; 2020 Sep; 36(11):163. PubMed ID: 32990838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Trends in Anti-Candida Drug Development.
    Dubey AK; Singla RK
    Curr Top Med Chem; 2019; 19(28):2525-2526. PubMed ID: 31876267
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel Therapies for Biofilm-Based Candida spp. Infections.
    Černáková L; Light C; Salehi B; Rogel-Castillo C; Victoriano M; Martorell M; Sharifi-Rad J; Martins N; Rodrigues CF
    Adv Exp Med Biol; 2019; 1214():93-123. PubMed ID: 31321751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Candida activity of essential oils.
    Palmeira-de-Oliveira A; Salgueiro L; Palmeira-de-Oliveira R; Martinez-de-Oliveira J; Pina-Vaz C; Queiroz JA; Rodrigues AG
    Mini Rev Med Chem; 2009 Oct; 9(11):1292-1305. PubMed ID: 19534688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Chemistry of Drugs to Treat Candida albicans.
    Ortiz A; Sansinenea E
    Curr Top Med Chem; 2019; 19(28):2554-2566. PubMed ID: 31654511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal drug resistance among Candida species: mechanisms and clinical impact.
    Sanguinetti M; Posteraro B; Lass-Flörl C
    Mycoses; 2015 Jun; 58 Suppl 2():2-13. PubMed ID: 26033251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species.
    Basso V; Garcia A; Tran DQ; Schaal JB; Tran P; Ngole D; Aqeel Y; Tongaonkar P; Ouellette AJ; Selsted ME
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.